Science Explorer Interactive view Map
Company · San Francisco · United States

Allogene Therapeutics (United States)

allogene.comROR OpenAlex
Research works
61
▲ 459% vs 2013–17
Citations
1.8k
30.0 per fractional work
Top-10% rate
28.4%
record average 16.5%
Open access
49%
world 28%

Not ranked overall: Allogene Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.32× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.01× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 11.85× its world share, 2 worksImmunology and Micro…Computer Science: 0.07× its world share, 0 worksComputer ScienceEngineering: 0.57× its world share, 2 worksEngineeringMathematics: 1.10× its world share, 0 worksMathematicsMedicine: 2.26× its world share, 9 worksMedicineDecision Sciences: 0.53× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.07× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 11.8×. Every wedge is a field page.

Who are the top researchers at Allogene Therapeutics (United States)?

Ranked on the composite score, Barbra J. Sasu lead among researchers whose main affiliation is Allogene Therapeutics (United States).

  1. 1 Barbra J. Sasu United States · #838,925 worldwide 26 citations · 15 works
All ranked researchers at Allogene Therapeutics (United States)

Which keywords describe research at Allogene Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Cancer Immunotherapy, Tumor Regression, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Glycosylation and Monoclonal Antibody.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 20 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Cancer Immunotherapy7▲ 203×3 topics
  2. Immunotherapy7▲ 44×5 topics
  3. Tumor Regression6▲ 269×2 topics
  4. Lymphoma6▲ 174×2 topics
  5. CAR T Cells6▲ 368×1 topic
  6. Chimeric Antigen Receptor6▲ 368×1 topic
  7. Glycosylation3▲ 140×2 topics
  8. Mammalian Cells3▲ 532×1 topic
  9. Monoclonal Antibody3▲ 245×2 topics
  10. Recombinant Protein3▲ 532×1 topic
  11. Monoclonal Antibodies2▲ 102×3 topics
  12. Gene Therapy2▲ 42×2 topics
  13. Biopharmaceuticals1▲ 127×3 topics
  14. Immunogenicity1▲ 147×2 topics
  15. AAV1▲ 141×1 topic
  16. Bioanalytical Methods1▲ 289×1 topic
  17. Biosimilars1▲ 289×1 topic
  18. Viral Vectors1▲ 141×1 topic
  19. Genome Engineering1▲ 73×1 topic
  20. RNA-Guided1▲ 73×1 topic

Which research topics does Allogene Therapeutics (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Viral Infectious Diseases and Gene Expression in Insects, Biosimilars and Bioanalytical Methods and Virus-based gene therapy research.

CAR-T cell therapy resea…6CAR-T cell therapy research: 6 fractional worksViral Infectious Diseases and Gene Expression in Insects: 3 fractional worksBiosimilars and Bioanalytical Methods: 1 fractional worksVirus-based gene therapy research: 1 fractional worksCRISPR and Genetic Engin…1CRISPR and Genetic Engineering: 1 fractional worksImmunotherapy and Immune Responses: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksNanowire Synthesis and Applications: 1 fractional worksCancer Research and Treatments: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional works
OncologyMolecular BiologyImmunologyGenetics3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 6 works
  2. 2 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 3 works
  3. 3 Biosimilars and Bioanalytical Methods Immunology 1 works
  4. 4 Virus-based gene therapy research Genetics 1 works
  5. 5 CRISPR and Genetic Engineering Molecular Biology 1 works
  6. 6 Immunotherapy and Immune Responses Immunology 1 works
  7. 7 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  8. 8 Nanowire Synthesis and Applications Biomedical Engineering 1 works
  9. 9 Cancer Research and Treatments Biotechnology 0 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.9%not open51.1%

World: 28% of research is openly available.

with international co-authors17.3%domestic only82.7%

World: 19% is written across borders.

How has Allogene Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 459% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Francisco

All research institutions in San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.